Skip to main content
PMC home page
Canadian Family Physician logoLink to Canadian Family Physician
. 1995 Nov;41:1868–1876.

Asthma and chronic bronchitis. Can family physicians predict rates of progression?

C P van Schayck 1, E Dompeling 1, R Putters 1, J Molema 1, C van Weel 1
PMCID: PMC2146732  PMID: 8563504

Abstract

OBJECTIVE: To investigate whether the progression rate of asthma or chronic bronchitis can be predicted from a cross-sectional assessment of features that can be measured by family physicians. DESIGN: Secondary analysis of data from a 2-year randomized, controlled bronchodilator intervention study in family practice. SETTING: Twenty-nine general practices in the eastern part of The Netherlands. PATIENTS: One hundred sixty patients (101 with chronic bronchitis, 59 with asthma) from the 29 general practices. INTERVENTIONS: Predictors were related to the annual decline in lung function (the forced expiratory volume in one second) by means of multiple analysis of variance, controlling for age, sex, smoking habits, initial FEV1 level, bronchial hyperresponsiveness, reversibility of obstruction, and medication during the study. MAIN OUTCOME MEASURES: Predictors of the annual decline in lung function (FEV1), which is believed to be the most important measure for progression. RESULTS: Only three variables predicted the decline in lung function: having a barrel-shaped chest, experiencing wheezing, and an unusual diurnal peak-flow rate index. Wheezing was the best predictor of the annual decline in lung function. In chronic bronchitis, the decline in FEV1 of wheezing patients was 133 mL/y compared with 62 mL/y for non-wheezing patients (P < 0.05). In asthma with more severe symptoms, wheezing patients had a tendency to decline 156 mL/y compared with 57 mL/y among non-wheezing patients (P = 0.08). CONCLUSIONS: It is nearly impossible to predict the progression rate of asthma or chronic bronchitis from symptoms, physical signs of the chest, and the PEFR. Therefore, patients with a rapid progression rate can probably be detected only by monitoring progression of the disease through repeated lung function testing.

Full text

PDF
1876

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barnes P. J. A new approach to the treatment of asthma. N Engl J Med. 1989 Nov 30;321(22):1517–1527. doi: 10.1056/NEJM198911303212206. [DOI] [PubMed] [Google Scholar]
  2. Beasley R., Cushley M., Holgate S. T. A self management plan in the treatment of adult asthma. Thorax. 1989 Mar;44(3):200–204. doi: 10.1136/thx.44.3.200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bel E. H., Timmers M. C., Hermans J., Dijkman J. H., Sterk P. J. The long-term effects of nedocromil sodium and beclomethasone dipropionate on bronchial responsiveness to methacholine in nonatopic asthmatic subjects. Am Rev Respir Dis. 1990 Jan;141(1):21–28. doi: 10.1164/ajrccm/141.1.21. [DOI] [PubMed] [Google Scholar]
  4. Burney P. G. Asthma mortality in England and Wales: evidence for a further increase, 1974-84. Lancet. 1986 Aug 9;2(8502):323–326. doi: 10.1016/s0140-6736(86)90012-7. [DOI] [PubMed] [Google Scholar]
  5. Burrows B., Bloom J. W., Traver G. A., Cline M. G. The course and prognosis of different forms of chronic airways obstruction in a sample from the general population. N Engl J Med. 1987 Nov 19;317(21):1309–1314. doi: 10.1056/NEJM198711193172103. [DOI] [PubMed] [Google Scholar]
  6. Burrows B., Knudson R. J., Camilli A. E., Lyle S. K., Lebowitz M. D. The "horse-racing effect" and predicting decline in forced expiratory volume in one second from screening spirometry. Am Rev Respir Dis. 1987 Apr;135(4):788–793. doi: 10.1164/arrd.1987.135.4.788. [DOI] [PubMed] [Google Scholar]
  7. Dompeling E., van Schayck C. P., Folgering H., van den Hoogen H. J., van Weel C. Accuracy, precision and linearity of the portable flow-volume meter Microspiro HI-298. Eur Respir J. 1991 May;4(5):612–615. [PubMed] [Google Scholar]
  8. Fletcher C., Peto R. The natural history of chronic airflow obstruction. Br Med J. 1977 Jun 25;1(6077):1645–1648. doi: 10.1136/bmj.1.6077.1645. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Forgacs P. The functional basis of pulmonary sounds. Chest. 1978 Mar;73(3):399–405. doi: 10.1378/chest.73.3.399. [DOI] [PubMed] [Google Scholar]
  10. Gregg I. The quality of care of asthma in general practice--a challenge for the future. Fam Pract. 1985 Jun;2(2):94–100. doi: 10.1093/fampra/2.2.94. [DOI] [PubMed] [Google Scholar]
  11. Haahtela T., Järvinen M., Kava T., Kiviranta K., Koskinen S., Lehtonen K., Nikander K., Persson T., Reinikainen K., Selroos O. Comparison of a beta 2-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma. N Engl J Med. 1991 Aug 8;325(6):388–392. doi: 10.1056/NEJM199108083250603. [DOI] [PubMed] [Google Scholar]
  12. Jones K. Asthma--still a challenge for general practice. J R Coll Gen Pract. 1989 Jun;39(323):254–256. [PMC free article] [PubMed] [Google Scholar]
  13. Juniper E. F., Kline P. A., Vanzieleghem M. A., Ramsdale E. H., O'Byrne P. M., Hargreave F. E. Effect of long-term treatment with an inhaled corticosteroid (budesonide) on airway hyperresponsiveness and clinical asthma in nonsteroid-dependent asthmatics. Am Rev Respir Dis. 1990 Oct;142(4):832–836. doi: 10.1164/ajrccm/142.4.832. [DOI] [PubMed] [Google Scholar]
  14. Kerrebijn K. F., van Essen-Zandvliet E. E., Neijens H. J. Effect of long-term treatment with inhaled corticosteroids and beta-agonists on the bronchial responsiveness in children with asthma. J Allergy Clin Immunol. 1987 Apr;79(4):653–659. doi: 10.1016/s0091-6749(87)80163-x. [DOI] [PubMed] [Google Scholar]
  15. Kerstjens H. A., Brand P. L., Hughes M. D., Robinson N. J., Postma D. S., Sluiter H. J., Bleecker E. R., Dekhuijzen P. N., de Jong P. M., Mengelers H. J. A comparison of bronchodilator therapy with or without inhaled corticosteroid therapy for obstructive airways disease. Dutch Chronic Non-Specific Lung Disease Study Group. N Engl J Med. 1992 Nov 12;327(20):1413–1419. doi: 10.1056/NEJM199211123272003. [DOI] [PubMed] [Google Scholar]
  16. Kraan J., Koëter G. H., vd Mark T. W., Sluiter H. J., de Vries K. Changes in bronchial hyperreactivity induced by 4 weeks of treatment with antiasthmatic drugs in patients with allergic asthma: a comparison between budesonide and terbutaline. J Allergy Clin Immunol. 1985 Oct;76(4):628–636. doi: 10.1016/0091-6749(85)90786-9. [DOI] [PubMed] [Google Scholar]
  17. Peat J. K., Woolcock A. J., Cullen K. Rate of decline of lung function in subjects with asthma. Eur J Respir Dis. 1987 Mar;70(3):171–179. [PubMed] [Google Scholar]
  18. Petty T. L. Chronic obstructive pulmonary disease--can we do better? Chest. 1990 Feb;97(2 Suppl):2S–5S. doi: 10.1378/chest.97.2.2s. [DOI] [PubMed] [Google Scholar]
  19. Postma D. S., de Vries K., Koëter G. H., Sluiter H. J. Independent influence of reversibility of air-flow obstruction and nonspecific hyperreactivity on the long-term course of lung function in chronic air-flow obstruction. Am Rev Respir Dis. 1986 Aug;134(2):276–280. doi: 10.1164/arrd.1986.134.2.276. [DOI] [PubMed] [Google Scholar]
  20. Ryan G., Latimer K. M., Dolovich J., Hargreave F. E. Bronchial responsiveness to histamine: relationship to diurnal variation of peak flow rate, improvement after bronchodilator, and airway calibre. Thorax. 1982 Jun;37(6):423–429. doi: 10.1136/thx.37.6.423. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Thom T. J. International comparisons in COPD mortality. Am Rev Respir Dis. 1989 Sep;140(3 Pt 2):S27–S34. doi: 10.1164/ajrccm/140.3_Pt_2.S27. [DOI] [PubMed] [Google Scholar]
  22. van Schayck C. P., Dompeling E., van Herwaarden C. L., Folgering H., Verbeek A. L., van der Hoogen H. J., van Weel C. Bronchodilator treatment in moderate asthma or chronic bronchitis: continuous or on demand? A randomised controlled study. BMJ. 1991 Dec 7;303(6815):1426–1431. doi: 10.1136/bmj.303.6815.1426. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. van Schayck C. P., Dompeling E., van Weel C., Folgering H., van den Hoogen H. J. Accuracy and reproducibility of the Assess peak flow meter. Eur Respir J. 1990 Mar;3(3):338–341. [PubMed] [Google Scholar]
  24. van Schayck C. P., van Weel C., Folgering H., Verbeek A. L., van Herwaarden C. L. Treatment of patients with airflow obstruction by general practitioners and chest physicians. Scand J Prim Health Care. 1989 Oct;7(3):137–142. doi: 10.3109/02813438909087230. [DOI] [PubMed] [Google Scholar]
  25. van Schayck C. P., van Weel C., Harbers H. J., van Herwaarden C. L. Do physical signs reflect the degree of airflow obstruction in patients with asthma or chronic obstructive pulmonary disease? Scand J Prim Health Care. 1991 Dec;9(4):232–238. doi: 10.3109/02813439109018525. [DOI] [PubMed] [Google Scholar]

Articles from Canadian Family Physician are provided here courtesy of College of Family Physicians of Canada

RESOURCES